A civil suit has been brought in the U.K. against a government agency over contaminated blood clotting products distributed thirty to forty years ago. The use of these unsafe products caused over 2,000 deaths from blood-related diseases like HIV as well as hepatitis C. The cut-off date to register in the class-action suit is November 29th, 2018. Over 760 claimants have already registered as of February, with an estimated further 20 claimants inquiring after registry after that. All further potential claimants can contact Collins Solicitors in Watford to be included in the suit. Other cases may be handle in future by solicitors Chester services or others in the UK.
According to attorneys involved in the case, agency under scrutiny has rather surprisingly elected to fight the impending claims of all members of the class-action suit. That group includes both the victims of the alleged actions of agency in question which is responsible for health and social service in the U.K., as well as family members of those directly affected by the products in question. The decision of by the government to fight the claims brought against it has brought outrage from participants in the suit, their attorneys, and members of the public. One of the attorneys at Collins Solicitors, a senior attorney, has said that the government agency responsible for the alleged deaths and threats to health and human safety, seems to be intent on intensifying the pain and suffering of the plaintiffs.
This would come not only from that which has already been endured but also the prolonged efforts at closure as well as exposure to public scrutiny about the specifics of the case as it pertains to individual members of the class. The phenomenon of a class-action lawsuit is one made familiar to people through the news as well as pop-culture; it’s a situation in which a large corporation is sued in civil court for wrongdoing by a group of people allegedly wronged by that corporation. Class-action suits have evolved as the primary way for members of the public to address grievances with huge entities with comparatively inexhaustible resources and funds for legal battle. Well known examples of this phenomenon are the actions brought against Big Tobacco, silicone implant manufacturers, Dukes v. Wal-Mart Stores in the United States for discrimination against women in promotions, pay and job assignments, and Canada’s tainted blood scandal which started in 1998 against the Canadian Red Cross for distributing contaminated blood when a test existed that would have prevented all deaths.
The precedent set by the claims listed above is for hundreds of millions, if not billions, of pounds in compensation for damages. The amount for which the claimants in the class will be suing the government group alleged to be responsible has not yet been disclosed to the public, but it would be reasonable to estimate the damages claim to be in keeping with these precedents. It should be noted that if the defendant agreed to settle the claim it would significantly cut down on the amount of time the claimants have to wait for compensation; critics of the defendant are outraged that it has voluntarily extended the timeline by fighting the claims brought against it.